Evidence map›Paper›PMID 42395815›Full record

ArticleRSC advances2026

Comparative binding and activity analysis of known serine hydroxymethyltransferase inhibitors in biochemical assays.

Julian Gräb, Christine Wagner, Charlotte Beber, Jennifer Szczesny, Stefan Rubner, Ioannis Papasotiriou

Abstract read
In one paragraph

Article in RSC advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Julian GräbResearch Genetic Cancer Centre Central Europe GmbH Weinbergweg 22 06120 Halle (Saale) Germany research@rgcc-centraleurope.com.
Christine WagnerResearch Genetic Cancer Centre Central Europe GmbH Weinbergweg 22 06120 Halle (Saale) Germany research@rgcc-centraleurope.com.
Charlotte BeberResearch Genetic Cancer Centre Central Europe GmbH Weinbergweg 22 06120 Halle (Saale) Germany research@rgcc-centraleurope.com.
Jennifer SzczesnyResearch Genetic Cancer Centre Central Europe GmbH Weinbergweg 22 06120 Halle (Saale) Germany research@rgcc-centraleurope.com.
Stefan RubnerResearch Genetic Cancer Centre Central Europe GmbH Weinbergweg 22 06120 Halle (Saale) Germany research@rgcc-centraleurope.com.ORCID https://orcid.org/0009-0004-4920-1863
Ioannis PapasotiriouResearch Genetic Cancer Centre International GmbH Baarerstrasse 95 6300 Zug Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Serine hydroxymethyltransferase (SHMT) is a crucial enzyme in folate metabolism, transferring a methylene group from serine to tetrahydrofolate (THF). It plays a key role in one-carbon metabolism, particularly in purine and thymidine biosynthesis, which has been linked to various cancers. Recently, a small number of small-molecule inhibitors distinct from traditional antifolates have been identified, such as SHIN1, SHIN2, AGF347 and W478. However, comprehensive cell-free biochemical data for binding and activity analysis of these inhibitors are lacking. By using thoroughly characterized recombinant SHMT1/2, this study investigates direct inhibitor binding by protein thermal shift assay and aims to expand the use of a known biochemical coupled enzyme approach, which has not yet been applied to determine the inhibitory activity of chemical test compounds, to evaluate the activity of these inhibitors against SHMT1 and SHMT2. Our work provides a comprehensive analysis of nine different SHMT1/2 inhibitors, thereby presenting a new methodological strategy that fills a gap in the existing literature on SHMT inhibition as well as opening up new avenues for the development and investigation of SHMT1/2 inhibitors.

Identifiers

PMID42395815
PMCPMC13325798

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.